Corrigendum to "Photothermic therapy with cuttlefish ink-based nanoparticles in combination with anti-OX40 mAb achieve remission of triple-negative breast cancer" [Int. Immunopharmacol. 115 (2023) 109622].

Niloofar Momenzadeh Sobhan Hajian Atefe Shabankare Reza Ghavimi Saber Kabiri-Samani Hamidreza Kabiri Khashayar Hesami-Zadeh Azar Najafi Tireh Shabankareh Roghayeh Nazaraghay Iraj Nabipour Mohsen Mohammadi

Int Immunopharmacol

The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA. Electronic address:

Published: November 2023

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.intimp.2023.111035	DOI Listing

Publication Analysis

Top Keywords

corrigendum "photothermic

"photothermic therapy

therapy cuttlefish

cuttlefish ink-based

ink-based nanoparticles

nanoparticles combination

combination anti-ox40

anti-ox40 mab

mab achieve

achieve remission

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!